Molecular Mechanisms

A probiotic therapy for autism

There is growing support for the idea that both genetic and environmental risk factors contribute to autism. One environmental risk is maternal infection, as validated by large epidemiological studies showing links between infection during pregnancy and autism in the child. Similar associations were found with elevated immune responses in maternal serum or amniotic fluid. Also consistent with an immune pathophysiology are findings of activated microglia — immune cells within the brain — in people with autism, as well as dysregulation of immune-related genes in the brain, cerebral spinal fluid and periphery.

A novel window into autism through genetic targeting of striatal subdivisions

A major goal of autism research is to understand the relationships among genetic etiology, altered developmental trajectory, aberrant neural circuits and behavioral symptoms characteristic of this disorder. Understanding how the functional activity of neural circuits is altered with cell-type resolution is likely to lead to more effective and targeted therapies. Among the neural circuits implicated in autism are ones involving the striatum, a structure buried deep within the brain that contributes to the evaluation and selection of behavior. Additionally, one gene associated with autism is SHANK3, which is important for the connections between neurons, including those within the striatum.

GABA-A receptor subtypes as therapeutic targets in autism

Nerve cells communicate with each other via excitatory and inhibitory signals. Growing evidence supports the hypothesis that a neuronal excitation/inhibition imbalance resulting in increased excitation in certain nerve cells in the brain is sufficient to elicit autism-like symptoms. Uwe Rudolph and his colleagues at McLean Hospital and Harvard Medical School focus on receptors for the major inhibitory neurotransmitter in the central nervous system, gamma-aminobutyric acid (GABA).

The role of cation/proton exchanger NHE9 in autism

Studies have identified a large number of genes that contribute to autism, and many affect communication between neurons, known as synaptic transmission. However, we do not understand the mechanisms responsible for the genes’ effects on synaptic transmission or how these effects give rise to abnormal behavior. To elucidate these mechanisms, Robert Edwards and his group at the University of California, San Francisco plan to study a protein of known biochemical function that has been implicated in autism and determine its role in synaptic physiology and behavior.

Disruption of cortico-cortical projection neurons, circuits and cognition in autism

Autism is most likely caused by changes in the development of the cerebral cortex, particularly in neural circuits that process social and cognitive information. Under- or over-connectivity in these circuits has been found in the brains of children and adults with autism. It remains unknown how altered development might lead to these disrupted connections. This knowledge is crucial for new diagnostic, preventive and therapeutic approaches in autism.

Role of the CUL3-mediated ubiquitination pathway in autism

A small protein called ubiquitin is added to other proteins to modify their function, causing changes in cellular behavior. Often, the addition of ubiquitin leads to the complete destruction of the tagged protein. This process, called ubiquitination, plays an important role in regulating the abundance of many proteins at neuronal junctions, or synapses, including receptors within the postsynaptic density (a brain region that contains receptors and other proteins that regulate neuronal function).

  • Previous Page
  • Viewing
  • Next Page
Subscribe to our newsletter and receive SFARI funding announcements and news